NewslettersESC & iPSC NewsScalable Manufacturing of Clinical-Grade Differentiated Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells for Regenerative TherapyBy Ishira - May 11, 20220166Scientists discuss the future directions for realizing hPSC-based cardiac regenerative therapy.[Cell Proliferation]Full Article